Clinical Trials on Epithelial Mesenchymal Transition in China

Total 3913 results

The First Affiliated Hospital of Zhengzhou University

Recruiting

Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Metastatic Gastric Cancer

China
First People's Hospital of Hangzhou

Enrolling by invitation

Spyglass+RFA Versus Cytobrush+RFA for Extrahepatic Cholangiocarcinoma

Malignant Biliary Obstruction | Extrahepatic Cholangiocarcinoma

China
Zhejiang University

Completed

18F-FAPI PET Imaging in Pancreatic Adenocarcinoma

Pancreas Adenocarcinoma | Diagnosis | Staging | 18F-FDG | 18F-FAPI

China
Hutchison Medipharma Limited

Active, not recruiting

A Phase II Study of HMPL-504 in Lung Sarcomatoid Carcinoma and Other Non-small Cell Lung Cancer

Lung Sarcomatoid Carcinoma

China
Air Force Military Medical University, China

Withdrawn

Water Method in Patients With Incomplete Colonoscopy

Pain | Adenoma | Failed or Difficult Intubation

China
Betta Pharmaceuticals Co., Ltd.

Completed

Icotinib as an Adjuvant Therapy for Patients With Stage IIA-IIIA Adenocarcinoma With EGFR Mutation (ICAPE)

Non-small Cell Lung Cancer

China
Tongji Hospital
Geneplus-Beijing Co. Ltd.; Chinese Cooperative Group of Liver Cancer (CCGLC)

Recruiting

Combined DEB-TACE, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma (CCGLC-012)

Cholangiocarcinoma Non-resectable

China
Hua Li

Recruiting

Combined Therapy Using D-TACE, Gemcitabine and Cisplatin, and PD1 Antibody in Advanced and Unresectable Intrahepatic Cholangiocarcinoma

Unresectable Intrahepatic Cholangiocarcinoma

China
Renmin Hospital of Wuhan University

Recruiting

Short-course Radiotherapy Combined With Neoadjuvant Chemotherapy and PD-1 Inhibitor in the Treatment of Locally Advanced Gastric Adenocarcinoma

Disorder in Complete Remission in Response to Treatment

China
Qingdao Central Hospital

Recruiting

Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma

Carcinoma, Adenoid Cystic

China
Renmin Hospital of Wuhan University

Completed

Endoscopic Quality Improvement System Study

Adenoma Colon | Gastric Precancerous Condition

China
Women's Hospital School Of Medicine Zhejiang University
Sun Yat-sen University; Qilu Hospital of Shandong University; Second Affiliated... and other collaborators

Recruiting

Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer

Epithelial Ovarian Carcinoma Stage III | Epithelial Ovarian Carcinoma Stage IV | Fallopian Tube Carcinoma Stage III | Fallopian Tube Carcinoma Stage IV | Primary Peritoneal Carcinoma Stage III | Primary Peritoneal Carcinoma Stage IV

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Nanjing Geneseeq Technology Inc.

Recruiting

Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Prospective Study)

Ovarian Cancer

China
Tongji Hospital
First Affiliated Hospital Xi'an Jiaotong University; Wuhan Union Hospital,... and other collaborators

Recruiting

A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer

Ovarian Cancer

China
Sun Yat-sen University

Completed

Apatinib and Etoposide in Patients With Platinum Resistant or Refractory Ovarian Cancer

Ovarian Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer

Ovarian Cancer

China
Sun Yat-sen University

Unknown

Study of Fludarabine With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer

Ovarian Cancer

China
The First Affiliated Hospital of Xiamen University

Recruiting

Individualized Precision Treatment Based on Ovarian Cancer Organoid Model

Ovarian Cancer

China
Zhongshan Hospital Xiamen University

Recruiting

Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer

Ovarian Cancer

China
Second Affiliated Hospital, School of Medicine,...

Recruiting

MESO-CAR T Cells Therapy for Relapsed and Refractory Epithelial Ovarian Cancer

Ovarian Cancer

China
Shenzhen Geno-Immune Medical Institute

Unknown

Genetically Modified T Cells Against Ovarian Cancer

Ovarian Cancer

China
Zhejiang University
Second Affiliated Hospital, School of Medicine, Zhejiang University; Hrain...

Unknown

MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

Ovarian Cancer

China
Fang Duan

Unknown

0.3% Sodium Hyaluronate Eye Drop to Prevent Recurrent Corneal Epithelium Exfoliation

Corneal Epithelium Exfoliation

China
AnHeart Therapeutics Inc.

Recruiting

IDH1 Inhibitor AB-218 in Patients With Advanced IDH1 Mutant Cholangiocarcinoma and Other Solid Tumor

Cholangiocarcinoma With IDH1 Mutation | Solid Tumors With IDH1 Mutation

China
Changhai Hospital
Xijing Hospital; First People's Hospital of Hangzhou; LanZhou University; Peking... and other collaborators

Withdrawn

Application of Endoscopic Scissors Cutting ENBD Tube in the Treatment of Malignant Hilar Biliary Strictures (ENBD)

Endoscopic Retrograde Cholangiopancreatography | Klatskin Tumor

China
Fudan University

Unknown

Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma

Malignant Neoplasm Other Gallbladder/Extrahepatic Bile Duct

China
Sino-Swed Pharmaceutical Corporation

Completed

The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients

Carcinoma Surgery | Parenteral Nutrition | Post-Operative Hospital Stay

China
Peking Union Medical College Hospital

Recruiting

New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence

Ovarian Cancer

China
Xinhua Hospital, Shanghai Jiao Tong University...

Withdrawn

Oral Topotecan Combined With Anlotinib in Patients With Platinum-resistant Recurrent Ovarian Cancer

Platinum-resistant Ovarian Cancer

China
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients

Ovarian Cancer

China
Hebei Medical University Fourth Hospital

Not yet recruiting

A Prospective, Randomized Controlled Study of Cyclophosphamide, Bevacizumab With or Without Envafolimab in Recurrent Epithelial Ovarian Cancer (EOC), Fallopian Tube Cancer, and Primary Peritoneal Cancer

Epithelial Ovarian Cancer

China
China Medical University, China

Recruiting

Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma.

Metastatic Colorectal Adenocarcinoma | MSS | pMMR

China
Qilu Pharmaceutical Co., Ltd.
Cend Therapeutics Inc.

Recruiting

CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma

Pancreatic Cancer

China
Peking University Third Hospital

Not yet recruiting

Study of Nimotuzumab Combined With IMRT in Elder Patients With Cervical Squamous Cell Carcinoma

Cervical Squamous Cell Carcinoma

China
Jing-yuan Fang, MD, Ph. D

Recruiting

Metformin for the Prevention of CRA Recurrence

Colorectal Adenoma | Metformin | Chemoprevention

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Study on the Consistency Evaluation of Organoids Used in the Clinical Treatment of Ovarian Cancer With Anti-tumor Drugs

Ovarian Cancer | Organoid

China
The Fourth Affiliated Hospital of Anhui Medical...

Completed

Precise Gene Signature for Predicting Outcomes in PDAC

Stage I-II Pancreatic Ductal Adenocarcinoma (PDAC) | Precise Prognostic and Predictive Signature

China
Shanghai Ninth People's Hospital Affiliated to...

Unknown

A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck

Adenoid Cystic Carcinoma

China
The Affiliated Hospital of the Chinese Academy...

Recruiting

Microtransplantation for Ovarian Cancer

Ovarian Cancer Recurrent

China
Cancer Institute and Hospital, Chinese Academy...
CSPC Ouyi Pharmaceutical Co., Ltd.

Not yet recruiting

Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in Ovarian Cancer.

Ovarian Cancer

China
Women's Hospital School Of Medicine Zhejiang University

Not yet recruiting

Effect of Compound Kushen Injection Combined With Pabolizumab in the Treatment of Cervical Adenocarcinoma

Cervical Cancer

China
Shi Ming

Suspended

Lenvatinib Plus PD-1 Antibody for Unresectable ICC

Intrahepatic Cholangiocarcinoma

China
Henan Cancer Hospital

Unknown

The FLOT Regimen Conversion Therapy of Adenocarcinoma of the Stomach / Gastroesophageal

Adenocarcinoma of the Stomach / Gastroesophageal

China
Fujian Cancer Hospital

Not yet recruiting

Study of the Apatinib Combine With POF Versus POF in Gastric Cancer

Gastric Adenocarcinoma | Advanced Cancer

China
First Affiliated Hospital Xi'an Jiaotong University
Shaanxi Provincial People's Hospital; Ningxia Medical University; Nanchang University and other collaborators

Completed

Routine Lymphadenectomy for Intrahepatic Cholangiocarcinoma (LND for ICC)

Intrahepatic Cholangiocarcinoma

China
First Affiliated Hospital, Sun Yat-Sen University
Guangdong Province, Department of Science and Technology

Unknown

VEGF Signaling Promotes Cell Growth and Metastasis in Extrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (ECC) (VEGF ECC)

Extrahepatic Cholangiocarcinoma

China
First Affiliated Hospital, Sun Yat-Sen University
Guangdong Province, Department of Science and Technology

Unknown

VEGF Signaling Promotes Cell Growth and Metastasis in Intrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway (icc)

Intrahepatic Cholangiocarcinoma

China
Fudan University

Not yet recruiting

The Efficacy and Safety of The Fuzuloparib Combination With Bevacizumab

Recurrent Ovarian Cancer

China
Chongqing University Cancer Hospital

Recruiting

Fluzoparib Combined With Bevacizumab in PSROC Previously Treated With PARPi

Ovarian Cancer

China
Sun Yat-sen University

Recruiting

Lymphadenectomy in Early Ovarian Cancer (LOVE)

Ovarian Cancer | Lymphadenectomy

China

Clinical Trials on Epithelial Mesenchymal Transition in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations